AGP Executive Report
Last update: 8 hours agoMedical AI & Markets: A South Korea-listed U.S. Medical AI ETF surged on Tempus AI’s jump, after analysts lifted revenue expectations tied to Medicare reimbursement for its tissue and liquid biopsy tests. Cancer & Drug Approvals: EMA CHMP backed perioperative pembrolizumab plus enfortumab vedotin for resectable muscle-invasive bladder cancer, moving the combo toward EU review. Mental Health Treatment Signals: A study links higher dissociation after subcutaneous esketamine to better outcomes in treatment-resistant depression, adding nuance to how patients experience the therapy. Healthcare Cybersecurity: CISA urged hospitals to use “cyber decoys” to speed detection of intrusions and reduce false alarms, especially for EHR and financial systems. Public Health Data: CDC is seeking input on how data intermediaries can improve secure, standards-based public health data exchange. Care Access in the UK: NHS Wales is set to open a £121m Llantrisant Health Park with six operating theatres to cut waiting times, targeting about 3,000 operations a year. Maternal & Infant Guidance: Nepal Pediatric Society reiterated that breast milk is the safest default, with formula substitutes only for specific, unavoidable situations. Hospital Safety Watch: A former nurse alleges long-standing warning signs before a Nashville drug mix-up injured joint-replacement patients. Weight-Loss Reality Check: A bariatric surgery patient warned that surgery isn’t a “quick fix” and that habits and support still matter.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
